A study on neutrophil-lymphocyte ratio and plateletlymphocyte ratio as an assessment tool of glycemic control in type 2 diabetes mellitus patients

dc.contributor.author	Dr. Veena Varier
dc.date.accessioned	2022-12-10T05:47:17Z
dc.date.available	2022-12-10T05:47:17Z
dc.date.issued	2019
dc.identifier.uri	http://hdl.handle.net/123456789/4598
dc.description.abstract	ABSTRACT INTRODUCTION Type 2 diabetes mellitus is one component of metabolic syndrome, which includes impaired glucose tolerance, hypertension, obesity, and dyslipidemia. White blood cell (WBC) count is linked to various components of metabolic syndrome, and subclinical inflammation may be associated with the increased cardiovascular risk in patients with impaired glucose tolerance. Neutrophil lymphocyte ratio (NLR) is an essential marker of systemic inflammation and an indicator of increased risk for cardiovascular events in patients with metabolic syndrome.	en_US
dc.language.iso	en	en_US
dc.publisher	BLDE(Deemed to be University)	en_US
dc.subject	A study on neutrophil-lymphocyte ratio and plateletlymphocyte ratio as an assessment tool of glycemic control in type 2 diabetes mellitus patients	en_US
dc.title	A study on neutrophil-lymphocyte ratio and plateletlymphocyte ratio as an assessment tool of glycemic control in type 2 diabetes mellitus patients	en_US
dc.type	Other	en_US